Skip to content

Opening book details…

About this Immunology and Microbiology article

Phase I study of cancer therapy with recombinant interleukin-2 administered by intravenous bolus injection by Evan M. Hersh; J. Lee Murray; Waun Ki Hong; Michael G. Rosenblum; James M. Reuben; Robert Weilbaecher; Amar N. Sarwal; Edward C. Bradley; Michael Konrad; Frank C. Arnett is a Immunology and Microbiology article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Immunology and Microbiology.

Author
Evan M. Hersh; J. Lee Murray; Waun Ki Hong; Michael G. Rosenblum; James M. Reuben; Robert Weilbaecher; Amar N. Sarwal; Edward C. Bradley; Michael Konrad; Frank C. Arnett
Publisher
Springer; Springer-Verlag; Springer International Publishing AG; Springer Science and Business Media LLC (ISSN 0921-299X)
Published
1989
Language
EN
Field
Immunology and Microbiology (Life Sciences)

More by Evan M. Hersh; J. Lee Murray; Waun Ki Hong; Michael G. Rosenblum; James M. Reuben; Robert Weilbaecher; Amar N. Sarwal; Edward C. Bradley; Michael Konrad; Frank C. Arnett

Browse all works by Evan M. Hersh; J. Lee Murray; Waun Ki Hong; Michael G. Rosenblum; James M. Reuben; Robert Weilbaecher; Amar N. Sarwal; Edward C. Bradley; Michael Konrad; Frank C. Arnett